The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance
Abstract
Mechanisms for observed associations within the major histocompatibility complex (MHC) and autoimmune diseases including multiple sclerosis (MS) remain uncertain. Genotyping of the HLA Class II DRB1 locus in 4347 individuals from 873 multiplex families with MS highlights the genetic complexity of this locus. Excess allele sharing in sibling pair families lacking DRB1*15 and DRB1*17 (58.5% sharing; P=0.012) was comparable to that seen where parents were DRB1*15 positive (62%, P=0.0006). DRB1*17 (P=0.00027) was clearly established as an MS susceptibility allele in addition to DRB1*15 (P<10(-14)). DRB1*14 showed striking under-transmission (P=0.000032) to affected offspring newly establishing this allele as a broadly acting resistance factor. Trans interactions were seen in both DRB1*15 and non-DRB1*15 bearing genotype combinations. DRB1*08 was transmitted preferentially with DRB1*15 (P=0.0114) and, in the presence of DRB1*08, the transmission of DRB1*15 was almost invariable (37 transmissions to one non-transmission). DRB1*01 was under-transmitted to offspring in the presence of DRB1*15 (P=0.019). Both DRB1*01 and DRB1*14 haplotypes carry DQA1*01-DQB1*05 alleles, suggesting a common DQ-related mechanism for the protection mediated by these haplotypes. These studies demonstrate that it is the Class II genotype that determines susceptibility and resistance to MS. By analogy with celiac disease and type I diabetes, the pattern of susceptibility strongly supports an autoimmune aetiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,651
Olerup, O., & Zetterquist, H. (1992) · Tissue Antigens · doi:10.1111/j.1399-0039.1992.tb01940.x · Cited by 1,796
Tiwari, J. L., & Terasaki, P. I. (1985) · Springer eBooks · doi:10.1007/978-1-4613-8545-5 · Cited by 876
A Genomic Screen of Autism: Evidence for a Multilocus Etiology
Risch, N., Spiker, D., Lotspeich, L., Nouri, N., Hinds, D., Hallmayer, J., Kalaydjieva, L., McCague, P., Dimiceli, S., Pitts, T., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302497 · Cited by 684 · cited 1×
“The proportion of simulated values that exceed the observed value is the derived empirical significance level (45).”
BackgroundSelf-citationA full genome search in multiple sclerosis
Ebers, G. C., Kukay, K., Bulman, D. E., Sadovnick, A. D., Rice, G., Anderson, C., Armstrong, H., Cousin, K., Bell, R. B., Hader, W., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-472 · Cited by 659
Self-citationA genetic basis for familial aggregation in multiple sclerosis
Ebers, G. C., Sadovnick, A. D., & Risch, N. J. (1995) · Nature · doi:10.1038/377150a0 · Cited by 615
Self-citationComplex HLA-DR and -DQ Interactions Confer Risk of Narcolepsy-Cataplexy in Three Ethnic Groups
Mignot, E., Lin, L., Rogers, W., Honda, Y., Qiu, X., Lin, X., Okun, M., Hohjoh, H., Miki, T., Hsu, S. H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318799 · Cited by 594
Self-citationGenetics of multiple sclerosis
Dyment, D. A., Ebers, G. C., & Dessa Sadovnick, A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00663-x · Cited by 563
Self-citationAssessing the role of HLA-linked and unlinked determinants of disease.
RISCH, N. J. (1987) · PubMed · Cited by 539
Self-citationTwin concordance and sibling recurrence rates in multiple sclerosis
Willer, C. J., Dyment, D. A., Risch, N. J., Sadovnick, A. D., Ebers, G. C., & The Canadian Collaborative Study Group§§ (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1932604100 · Cited by 532
Self-citationEvidence for genetic basis of multiple sclerosis
Sadovnick, A. D., the Canadian Collaborative Study Group, Dyment, D. A., Ebers, G. C., & Risch, N. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90807-7 · Cited by 351
Self-citationMapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans
Oksenberg, J. R., Barcellos, L. F., Cree, B. A. C., Baranzini, S. E., Bugawan, T. L., Khan, O., Lincoln, R. R., Swerdlin, A., Mignot, E., Lin, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380997 · Cited by 340
HL-A ANTIGENS AND MULTIPLE SCLEROSIS
Jersild, C., Svejgaard, A., & Fog, T. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90962-2 · Cited by 324
Multiple Sclerosis: Association with HL—A3
NAITO, S., NAMEROW, N., MICKEY, M. R., & TERASAKI, P. I. (1972) · Tissue Antigens · doi:10.1111/j.1399-0039.1972.tb00111.x · Cited by 308
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R. R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
Haines, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1229 · Cited by 284
Margaritte‐Jeannin, P., Babron, M. C., Bourgey, M., Louka, A. S., Clot, F., Percopo, S., Coto, I., Hugot, J. P., Ascher, H., Sollid, L. M., et al. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00237.x · Cited by 199
Marrosu, M. G., Murru, R., Murru, M. R., Costa, G., Zavattari, P., Whalen, M., Cocco, E., Mancosu, C., Schirru, L., Solla, E., et al. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2907 · Cited by 180
Major histocompatibility complex class II alleles and the course and outcome of MS
Weinshenker, B. G., Santrach, P. J., Bissonet, A. S., McDonnell, S. K., Schaid, D. J., Moore, S. B., & Rodríguez, M. T. (1998) · Neurology · doi:10.1212/wnl.51.3.742 · Cited by 152
Marrosu, M. G., Murru, M. R., Costa, G., Cucca, F., Sotgiu, S., Rosati, G., & Muntoni, F. (1997) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)64074-9 · Cited by 145
Siminovitch, K. A. (2004) · Nature Genetics · doi:10.1038/ng1204-1248 · Cited by 143
Fogdell‐Hahn, A., Hillert, J. A., Sachs, C., & Olerup, O. (1995) · Tissue Antigens · doi:10.1111/j.1399-0039.1995.tb02503.x · Cited by 124
Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method
Sadovnick, A. D., RISCH, N. J., Ebers, G. C., & the Canadian Collaborative Study Group (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034041 · Cited by 119
Self-citationBegovich, A. B., Caillier, S. J., Alexander, H. C., Penko, J. M., Hauser, S. L., Barcellos, L. F., & Oksenberg, J. R. (2004) · The American Journal of Human Genetics · doi:10.1086/427244 · Cited by 114
Hudson, T. J. (2003) · Nature Genetics · doi:10.1038/ng0403-439 · Cited by 109
Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease
Koeleman, B. P. C., Lie, B. A., Undlien, D. E., Dudbridge, F., Thorsby, E., Vries, D. R., Cucca, F., Roep, B. O., Giphart, M. J., & Todd, J. A. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364106 · Cited by 108
Madigand, M., Oger, J. J.-F., Fauchet, R., Sabouraud, O., & GENETET, B. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90248-9 · Cited by 107
Ôta, M., Katsuyama, Y., Kimura, A., Tsuchiya, K., Kondo, M., Naruse, T. K., Mizuki, N., Itoh, K., Sasazuki, T., & Inoko, H. (2001) · Genomics · doi:10.1006/geno.2000.6371 · Cited by 105
Rubio, J. P., Bahlo, M., Butzkueven, H., van der Mei, I. A. F., Sale, M. M., Dickinson, J. L., Groom, P., Johnson, L., Simmons, R. D., Tait, B. D., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339932 · Cited by 94
HLA-DR and -DQ Associations with Multiple Sclerosis in Turkey
Saruhan‐Direskeneli, G., Esin, S., Baykan, B. B., Örnek, I., Vaughan, R., & Eraksoy, M. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00086-4 · Cited by 94
B-cell alloantigen Ag 7a in multiple sclerosis
Winchester, R. J., Ebers, G. C., Fu, S. M., Espinosa, L., Zabriskie, J. B., & Kunkel, H. G. (1975) · The Lancet · doi:10.1016/s0140-6736(75)80033-x · Cited by 92
Self-citationZavattari, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.8.881 · Cited by 79
DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro‐Brazilians
Caballero, A., Alves‐Leon, S. V., Papais‐Alvarenga, R., Fernández, Ó., Navarro, G., & Alonso, A. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.540511.x · Cited by 78
Evidence of Linkage with HLA-DR in DRB1*15-Negative Families with Multiple Sclerosis
Ligers, A., Dyment, D. A., Willer, C. J., Sadovnick, A. D., Ebers, G. C., RISCH, N. J., & Hillert, J. A. (2001) · The American Journal of Human Genetics · doi:10.1086/323480 · Cited by 76
Self-citationHLA and prognosis in multiple sclerosis
Runmarker, B., Martinsson, T., Wahlström, J., & Andersen, O. (1994) · Journal of Neurology · doi:10.1007/bf02033356 · Cited by 61
Allcock, R. J. N., de la Concha, E. G., Fernández‐Arquero, M., Vigil, P., Conejero, L., Arroyo, R., & Price, P. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00127-5 · Cited by 58
HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis
la Barrera, C. A., Zúñiga, J., Ruiz‐Morales, J., Estañol, B., Granados, J., & Llorente, L. (2000) · Neurology · doi:10.1212/wnl.55.12.1897 · Cited by 51
Progress in deciphering the genetics of multiple sclerosis
Herrera, B. M., & Ebers, G. C. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000073924.19076.bb · Cited by 42
Self-citationHLA-DR and -DQ DNA genotyping in multiple sclerosis patients in Northern Ireland
Cullen, C., Middleton, D., Savage, D. A., & Hawkins, S. A. (1991) · Human Immunology · doi:10.1016/0198-8859(91)90062-e · Cited by 31
The combination of HLA-DR1 and HLA-DR53 protects against MS
Luomala, M., Elovaara, I., Ukkonen, M., Koivula, T., & Lehtimäki, T. J. (2001) · Neurology · doi:10.1212/wnl.56.3.383 · Cited by 24
Pina, M. A., Ara, J. R., Lasierra, P., Modrego, P. J., & Larrad, L. (1999) · Neuroepidemiology · doi:10.1159/000026212 · Cited by 21
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Cited by
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
“In addition, the analysis also explains why those haplotypes carrying the *08:01 allele have previously been shown to increase ris”
BackgroundThe Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
Environmental factors and multiple sclerosis
Ebers, G. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70042-5 · Cited by 629
Self-citationEpigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Urdinguio, R. G., Sanchez-Mut, J. V., & Esteller, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70262-5 · Cited by 582
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70094-6 · Cited by 548
Metadata
- Authors
- Dyment, D. A., Herrera, B. M., Cader, M. Z., Willer, C. J., Lincoln, M. R., Sadovnick, A. D., Risch, N., & Ebers, G. C.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-01
- Volume
- 14
- Issue
- 14
- Pages
- 2019-2026
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2134156548
- Cited by
- 252
- References
- 45
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.